Buprenorphine Transdermal System for Opioid Therapy in Patients with Chronic Low Back Pain

Allan Gordon; Saifudin Rashiq; Dwight E Moulin; Alexander J Clark; André D Beaulieu; John Eisenhoffer; Paula S Piraino; Patricia Quigley; Zoltan Harsanyi; Andrew C Darke

doi:10.1155/2010/216725

Pain Research and Management (Jan 2010)

Buprenorphine Transdermal System for Opioid Therapy in Patients with Chronic Low Back Pain

Allan Gordon,
Saifudin Rashiq,
Dwight E Moulin,
Alexander J Clark,
André D Beaulieu,
John Eisenhoffer,
Paula S Piraino,
Patricia Quigley,
Zoltan Harsanyi,
Andrew C Darke

Affiliations

Allan Gordon: Mount Sinai Hospital, Toronto, Ontario, Canada
Saifudin Rashiq: University of Alberta Hospital, Edmonton, Alberta, Canada
Dwight E Moulin: London Health Sciences Centre, London, Ontario, Canada
Alexander J Clark: University of Calgary, Calgary, Alberta, Canada
André D Beaulieu: Centre de Rhumatologie St-Louis, Ste Foy, Quebec, Canada
John Eisenhoffer: Purdue Pharma, Pickering, Ontario, Canada
Paula S Piraino: Purdue Pharma, Pickering, Ontario, Canada
Patricia Quigley: Astellas Pharma US Inc, Deerfield, Illinois, USA
Zoltan Harsanyi: Purdue Pharma, Pickering, Ontario, Canada
Andrew C Darke: Purdue Pharma, Pickering, Ontario, Canada

DOI: https://doi.org/10.1155/2010/216725
Journal volume & issue: Vol. 15, no. 3
pp. 169 – 178

Abstract

Read online

OBJECTIVE: The present randomized, double-blinded, crossover study compared the efficacy and safety of a seven-day buprenorphine transdermal system (BTDS) and placebo in patients with low back pain of moderate or greater severity for at least six weeks.

Published in Pain Research and Management

ISSN: 1203-6765 (Print); 1918-1523 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/7040

About the journal